Caveolae: A regulatory platform for nutritional modulation of inflammatory diseases

Journal of Nutritional Biochemistry

Volumn 22, Issue 9, 2011, Pages 807-811

  Layne, Joseph ^a,b   Majkova, Zuzana ^a   Smart, Eric J ^b   Toborek, Michal ^b   Hennig, Bernhard ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Caveolae; Inflammatory diseases; Nutritional modulation

Indexed keywords

CAVEOLIN 1; NITRIC OXIDE; OMEGA 3 FATTY ACID; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CAVEOLA; CELL FUNCTION; DIET THERAPY; ENDOTHELIAL DYSFUNCTION; ENZYME REGULATION; HUMAN; INFLAMMATORY DISEASE; LIPID RAFT; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULITIS;

ATHEROSCLEROSIS; CAVEOLAE; CAVEOLIN 1; DIETARY SUPPLEMENTS; ENDOTHELIAL CELLS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; NF-E2-RELATED FACTOR 2; NITRIC OXIDE; OXIDATIVE STRESS; POLYPHENOLS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 79958240083     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.09.013     Document Type: Article

References (69)

1. Frank P.G., Lee H., Park D.S., Tandon N.N., Scherer P.E., Lisanti M.P. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:98-105.
2. Mineo C., Shaul P.W. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc Res 2006, 70:31-41.
3. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997, 272:6525-6533.
4. Fernandez-Hernando C., Yu J., Suarez Y., Rahner C., Davalos A., Lasuncion M.A., et al. Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab 2009, 10:48-54.
5. Chen W., Jump D.B., Esselman W.J., Busik J.V. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007, 48:18-26.
6. Wang L., Lim E.J., Toborek M., Hennig B. The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation. Metabolism 2008, 57:1328-1339.
7. D'Alessio A., Al-Lamki R.S., Bradley J.R., Pober J.S. Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line. Am J Pathol 2005, 166:1273-1282.
8. Wang X.M., Kim H.P., Nakahira K., Ryter S.W., Choi A.M. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 2009, 182:3809-3818.
9. Garrean S., Gao X.P., Brovkovych V., Shimizu J., Zhao Y.Y., Vogel S.M., et al. Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol 2006, 177:4853-4860.
10. Mirza M.K., Yuan J., Gao X.P., Garrean S., Brovkovych V., Malik A.B., et al. Caveolin-1 deficiency dampens Toll-like receptor 4 signaling through eNOS activation. Am J Pathol 2010, 176:2344-2351.
11. Clapp B.R., Hingorani A.D., Kharbanda R.K., Mohamed-Ali V., Stephens J.W., Vallance P., et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004, 64:172-178.
12. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkappaBalpha. J Biol Chem 1997, 272:30969-30974.
13. Venema R.C., Sayegh H.S., Arnal J.F., Harrison D.G. Role of the enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J Biol Chem 1995, 270:14705-14711.
14. Ju H., Zou R., Venema V.J., Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 1997, 272:18522-18525.
15. Hung M.J., Cherng W.J., Hung M.Y., Wu H.T., Pang J.H., Malik A.B., et al. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells. J Hypertens 2010, 28:940-951.
16. Vasquez-Vivar J., Kalyanaraman B., Martasek P., Hogg N., Masters B.S., Karoui H., et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A 1998, 95:9220-9225.
17. Du Y.H., Chen A.F. A new role for caveolin-1: regulation of guanosine triphosphate cyclohydrolase I and tetrahydrobiopterin in endothelial cells. Hypertension 2009, 53:115-117.
18. Yang N., Ying C., Xu M., Zuo X., Ye X., Liu L., et al. High-fat diet up-regulates caveolin-1 expression in aorta of diet-induced obese but not in diet-resistant rats. Cardiovasc Res 2007, 76:167-174.
19. 2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 2004, 286:H1001-1007.
20. Weber C., Erl W., Pietsch A., Strobel M., Ziegler-Heitbrock H.W., Weber P.C. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb 1994, 14:1665-1673.
21. Oakley F.D., Smith R.L., Engelhardt J.F. Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem 2009, 284:33255-33264.
22. Singleton P.A., Pendyala S., Gorshkova I.A., Mambetsariev N., Moitra J., Garcia J.G., et al. Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endothelium. J Biol Chem 2009, 284:34964-34975.
23. Tiruppathi C., Shimizu J., Miyawaki-Shimizu K., Vogel S.M., Bair A.M., Minshall R.D., et al. Role of NF-kappaB-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide. J Biol Chem 2008, 283:4210-4218.
24. Zakkar M., Van der Heiden K., Luong le A., Chaudhury H., Cuhlmann S., Hamdulay S.S., et al. Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state. Arterioscler Thromb Vasc Biol 2009, 29:1851-1857.
25. Fujii S, Sawa T, Ihara H, Tong KI, Ida T, Okamoto T, et al. The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response. J Biol Chem 2010, 285(31):23970-23984.
26. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001, 276:38121-38138.
27. Loboda A., Jazwa A., Grochot-Przeczek A., Rutkowski A.J., Cisowski J., Agarwal A., et al. Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2008, 10:1767-1812.
28. Sugiyama T., Michel T. Thiol-metabolizing proteins and endothelial redox state: differential modulation of eNOS and biopterin pathways. Am J Physiol Heart Circ Physiol 2010, 298:H194-H201.
29. Volonte D., Galbiati F. Inhibition of thioredoxin reductase 1 by caveolin 1 promotes stress-induced premature senescence. EMBO Rep 2009, 10:1334-1340.
30. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002, 106:544-549.
31. Roy Chowdhury S.K., Sangle G.V., Xie X., Stelmack G.L., Halayko A.J., Shen G.X. Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am J Physiol Endocrinol Metab 2009.
32. Blair A., Shaul P.W., Yuhanna I.S., Conrad P.A., Smart E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 1999, 274:32512-32519.
33. Nisoli E., Tonello C., Cardile A., Cozzi V., Bracale R., Tedesco L., et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005, 310:314-317.
34. Quinlan C.L., Costa A.D., Costa C.L., Pierre S.V., Dos Santos P., Garlid K.D. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol 2008, 295:H953-H961.
35. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
36. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
37. Schulz E., Dopheide J., Schuhmacher S., Thomas S.R., Chen K., Daiber A., et al. Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 2008, 118:1347-1357.
38. Hattori Y., Suzuki K., Hattori S., Kasai K. Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension 2006, 47:1183-1188.
39. Levine Y.C., Li G.K., Michel T. Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK->Rac1->Akt->endothelial nitric-oxide synthase pathway. J Biol Chem 2007, 282:20351-20364.
40. Chapkin R.S., Kim W., Lupton J.R., McMurray D.N. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009, 81:187-191.
41. Wang TM, Chen CJ, Lee TS, Chao HY, Wu WH, Hsieh SC, et al. Docosahexaenoic acid attenuates VCAM-1 expression and NF-kappaB activation in TNF-alpha-treated human aortic endothelial cells. J Nutr Biochem 2010.
42. Chapkin R.S., McMurray D.N., Davidson L.A., Patil B.S., Fan Y.Y., Lupton J.R. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 2008, 100:1152-1157.
43. Ma D.W., Seo J., Davidson L.A., Callaway E.S., Fan Y.Y., Lupton J.R., et al. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon. FASEB J 2004, 18:1040-1042.
44. Wassall S.R., Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids 2008, 153:57-63.
45. Schaefer M.B., Wenzel A., Fischer T., Braun-Dullaeus R.C., Renner F., Dietrich H., et al. Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis. Atherosclerosis 2008, 197:630-637.
46. Li Q., Zhang Q., Wang M., Zhao S., Ma J., Luo N., et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007, 89:169-177.
47. Li Q., Zhang Q., Wang M., Liu F., Zhao S., Ma J., et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007, 466:250-259.
48. Wong S.W., Kwon M.J., Choi A.M., Kim H.P., Nakahira K., Hwang D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284:27384-27392.
49. Maloney E., Sweet I.R., Hockenbery D.M., Pham M., Rizzo N.O., Tateya S., et al. Activation of NF-kappaB by palmitate in endothelial cells: a key role for NADPH oxidase-derived superoxide in response to TLR4 activation. Arterioscler Thromb Vasc Biol 2009, 29:1370-1375.
50. Loke W.M., Proudfoot J.M., Hodgson J.M., McKinley A.J., Hime N., Magat M., et al. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 2009, 30:749-757.
51. Yamagata K., Miyashita A., Matsufuji H., Chino M. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. J Nutr Biochem 2010, 21:116-124.
52. Lee Y.W., Lee W.H. Protective effects of genistein on proinflammatory pathways in human brain microvascular endothelial cells. J Nutr Biochem 2008, 19:819-825.
53. Yang H.L., Chen W.Q., Cao X., Worschech A., Du L.F., Fang W.Y., et al. Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model. J Transl Med 2009, 7:22.
54. Kawai Y., Nishikawa T., Shiba Y., Saito S., Murota K., Shibata N., et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008, 283:9424-9434.
55. Wu C.C., Wang S.H., Kuan I.I., Tseng W.K., Chen M.F., Wu J.C., et al. OxLDL upregulates caveolin-1 expression in macrophages: role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium. J Cell Biochem 2009, 107:460-472.
56. Csiszar A., Labinskyy N., Pinto J.T., Ballabh P., Zhang H., Losonczy G., et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 2009, 297:H13-20.
57. Klinge C.M., Wickramasinghe N.S., Ivanova M.M., Dougherty S.M. Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 2008, 22:2185-2197.
58. Woodman O.L., Missen M.A., Boujaoude M. Daidzein and 17 beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharmacol 2004, 44:155-163.
59. Sobey C.G., Weiler J.M., Boujaoude M., Woodman O.L. Effect of short-term phytoestrogen treatment in male rats on nitric oxide-mediated responses of carotid and cerebral arteries: comparison with 17beta-estradiol. J Pharmacol Exp Ther 2004, 310:135-140.
60. Li Y., Ying C., Zuo X., Yi H., Yi W., Meng Y., et al. Green tea polyphenols down-regulate caveolin-1 expression via ERK1/2 and p38MAPK in endothelial cells. J Nutr Biochem 2009, 20:1021-1027.
61. Zheng Y., Lim E.J., Wang L., Smart E.J., Toborek M., Hennig B. Role of caveolin-1 in EGCG-mediated protection against linoleic-acid-induced endothelial cell activation. J Nutr Biochem 2009, 20:202-209.
62. Kim J.A., Formoso G., Li Y., Potenza M.A., Marasciulo F.L., Montagnani M., et al. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 2007, 282:13736-13745.
63. Morrow V.A., Foufelle F., Connell J.M., Petrie J.R., Gould G.W., Salt I.P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 2003, 278:31629-31639.
64. Collins Q.F., Liu H.Y., Pi J., Liu Z., Quon M.J., Cao W. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem 2007, 282:30143-30149.
65. Schroeder E.K., Kelsey N.A., Doyle J., Breed E., Bouchard R.J., Loucks F.A., et al. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signal 2009, 11:469-480.
66. Fiorani M., Guidarelli A., Blasa M., Azzolini C., Candiracci M., Piatti E., et al. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J Nutr Biochem 2010, 21:397-404.
67. Sanchez M., Galisteo M., Vera R., Villar I.C., Zarzuelo A., Tamargo J., et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006, 24:75-84.
68. Vera R., Sanchez M., Galisteo M., Villar I.C., Jimenez R., Zarzuelo A., et al. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci (Lond) 2007, 112:183-191.
69. Hardin C.D., Vallejo J. Caveolins in vascular smooth muscle: form organizing function. Cardiovasc Res 2006, 69:808-815.